+ Follow SHEMBERG BIOTECH Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 662031
[Title] => Shemberg moving operations to Indonesia
[Summary] => Shemberg Marketing Corp. and Shemberg Biotech, both owned by Cebuano businessman Benson Dakay, is planning to move its manufacturing operations from Cebu to Indonesia.
[DatePublished] => 2011-03-03 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1805266
[AuthorName] => Marianne V. Go
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[1] => Array
(
[ArticleID] => 648385
[Title] => Carageenan exporter eyes 23% revenue growth
[Summary] => The Shemberg group owned by Cebu businessman Benson Dakay is projecting a 23-percent growth in export revenues this year.
[DatePublished] => 2011-01-17 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1805266
[AuthorName] => Marianne V. Go
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[2] => Array
(
[ArticleID] => 260483
[Title] => Shemberg shifts to non-traditional uses of carrageenan
[Summary] => Shemberg Corp. has shifted its focus to developing new markets especially for non-traditional applications of carrageenan such as oral care products, soft and hard capsules and microbicidal gels and foams. Since 1978, Shemberg has been processing carrageenan for various applications in food like meat, dairy, water jellies, gummy candies, petfood and air freshener gels.
[DatePublished] => 2004-08-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Agriculture
[SectionUrl] => agriculture
[URL] =>
)
[3] => Array
(
[ArticleID] => 194859
[Title] => Shemberg Biotech incurs P179-M loss
[Summary] => Shemberg Biotech Corp. incurred a net loss of P179.10 million in the first 10 months of 2002, the companys income statement showed yesterday.
Compared to its full-year net loss of P168.25 million in 2001, Shemberg Biotech, however, was able to minimally spare down from P199.20 million in 2000.
Shemberg Biotech, registered with the Securities and Exchange Commission on Dec. 22, 1989, is engaged in farming and culturing of seaweeds and in the processing, preserving and manufacture of highly-refined carrageenan and its by-products.
[DatePublished] => 2003-02-10 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
)
)
SHEMBERG BIOTECH
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 662031
[Title] => Shemberg moving operations to Indonesia
[Summary] => Shemberg Marketing Corp. and Shemberg Biotech, both owned by Cebuano businessman Benson Dakay, is planning to move its manufacturing operations from Cebu to Indonesia.
[DatePublished] => 2011-03-03 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1805266
[AuthorName] => Marianne V. Go
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[1] => Array
(
[ArticleID] => 648385
[Title] => Carageenan exporter eyes 23% revenue growth
[Summary] => The Shemberg group owned by Cebu businessman Benson Dakay is projecting a 23-percent growth in export revenues this year.
[DatePublished] => 2011-01-17 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] => 1805266
[AuthorName] => Marianne V. Go
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
[2] => Array
(
[ArticleID] => 260483
[Title] => Shemberg shifts to non-traditional uses of carrageenan
[Summary] => Shemberg Corp. has shifted its focus to developing new markets especially for non-traditional applications of carrageenan such as oral care products, soft and hard capsules and microbicidal gels and foams. Since 1978, Shemberg has been processing carrageenan for various applications in food like meat, dairy, water jellies, gummy candies, petfood and air freshener gels.
[DatePublished] => 2004-08-08 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Agriculture
[SectionUrl] => agriculture
[URL] =>
)
[3] => Array
(
[ArticleID] => 194859
[Title] => Shemberg Biotech incurs P179-M loss
[Summary] => Shemberg Biotech Corp. incurred a net loss of P179.10 million in the first 10 months of 2002, the companys income statement showed yesterday.
Compared to its full-year net loss of P168.25 million in 2001, Shemberg Biotech, however, was able to minimally spare down from P199.20 million in 2000.
Shemberg Biotech, registered with the Securities and Exchange Commission on Dec. 22, 1989, is engaged in farming and culturing of seaweeds and in the processing, preserving and manufacture of highly-refined carrageenan and its by-products.
[DatePublished] => 2003-02-10 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Business
[SectionUrl] => business
[URL] =>
)
)
)
abtest
February 10, 2003 - 12:00am